Palladium‐Catalyzed Enantioselective Arylative Dearomatization of Naphthols and Phenols for Constructing Quinazoline‐Containing Spirocycles
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202503359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Chiyue Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Hauptthemen laut MEDLINE: Palladium, Quinazolines, Phenols, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Shanghai Institute of Material Medica (SIMM), Science and Technology Commission of Shanghai Municipality, Shanghai Pujiang Program.
Abstract (Originalsprache)
We report a palladium‐catalyzed enantioselective arylative dearomatization of phenols and naphthols, demonstrating a broad substrate scope and excellent functional group tolerance. This approach enables the efficient construction of a diverse library of quinazoline‐containing spirocyclic compounds, featuring enantioenriched, three‐dimensional molecular architectures through the strategic integration of quinazolinone and spirocyclic frameworks. The successful transformation of planar aromatic precursors into complex three‐dimensional molecular architectures using our developed methodology was further validated by principal moment of inertia (PMI) calculations. Additionally, we systematically evaluated the antiproliferative potential of the synthesized compounds against two representative cancer cell lines: Mino (human mantle cell lymphoma) and MV4‐11 (human acute myeloid leukemia), revealing that compound ( S )‐4ac, characterized by well‐defined stereochemistry and structural novelty, exhibited significantly enhanced antiproliferative efficacy against both cancer cell lines, with IC 50 values 0.9 µM and 0.5 µM, respectively. In addition, flow cytometry quantification and western blot analysis showed that these compounds induced apoptosis through caspase activation and mitochondrial dysfunction. These results demonstrated ( S )‐4ac as a highly promising lead compound for further anticancer drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
- State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
- The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528400, China.
Förderung
- Shanghai Institute of Material Medica (SIMM), Science and Technology Commission of Shanghai Municipality
- Shanghai Pujiang Program
Zitieren
APA
Zhang, C., Xu, G., Zhao, W., Li, X., Zheng, M., Zhou, Y., Li, J., & Li, Q. (2025). Palladium‐Catalyzed Enantioselective Arylative Dearomatization of Naphthols and Phenols for Constructing Quinazoline‐Containing Spirocycles. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202503359
Vancouver
Zhang C, Xu G, Zhao W, Li X, Zheng M, Zhou Y, et al. Palladium‐Catalyzed Enantioselective Arylative Dearomatization of Naphthols and Phenols for Constructing Quinazoline‐Containing Spirocycles. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202503359
BibTeX
@article{Zhang2025,
author = {Zhang, Chiyue and Xu, Gaoya and Zhao, Wenlu and Li, Xutong and Zheng, Mingyue and Zhou, Yubo and Li, Jia and Li, Qi},
title = {Palladium‐Catalyzed Enantioselective Arylative Dearomatization of Naphthols and Phenols for Constructing Quinazoline‐Containing Spirocycles},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202503359}
}
EUVIMED